Adria Carbo is a former PhD student in the NIMML, studying Genomics, Bioinformatics, and Computational Biology with a B.S. in Biotechnology from Barcelona. He has held internships with Vall Hebron Hospital, the Biostatics Biomedical Unit at the University of Barcelona, and NIMML. Adria has researched CD4+ T-cell differentiation since he was an Undergraduate Research Assistant, with a focus on creating an expansive computational model. His work carries over into the wet lab, including the immune response to an infection by Helicobacter pylori. Much of his work was done with the Center for Modeling Immunity to Enteric Pathogens, or MIEP. After leaving NIMML, Dr. Carbo became the Scientific Director and Head of Business Development at Biotherapeutics. He currently holds the position of Director, Drug Discovery Business Development at Adaptive Biotechnologies Corporation.